Laxmi Organic Industries Ltd. · NSE:LXCHEM
Laxmi Organic Industries — Q1 FY26 Earnings Presentation
33 slides from Laxmi Organic Industries's earnings presentation, Jul 28, 2025
Slide 1: Intimation of Analyst / Institutional Investors' meeting presentation
July 28, 2025 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, 1st Floor, New Trading Ring, Bandra (E), Rotunda Building, P. J. Towers, Mumbai – 400 051 Dalal Street, Fort, Trading Symbol: LXCHEM Mumbai – 400 001 Scrip Code
Slide 2: Geared to Win; Geared for Growth – Investor Presentation Q1 FY26
Geared to Win; Geared for Growth Investor Presentation – Q1 FY26 July 2025 www.laxmi.com
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), have been prepared by Laxmi Organic Industries Limited (the “Company”) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities and shall no
Slide 4: Company Overview
Company Overview www.laxmi.com
Slide 5: Laxmi Organic Industries Ltd. – A Leading Indian Chemical Company
Laxmi Organic Industries Ltd. – A Leading Indian Chemical Company Essentials BU - Lean & Reliable Specialties BU - World Class Technology Supplier serving diverse industries platforms with strong development capabilities serving diverse industries Emphasis on Development, Quality, and ESG. Large, gl
Slide 6: Diversified Business Catering to Varied Industries
Diversified Business Catering to Varied Industries Essentials Specialties Pharmaceuticals Agrochemicals Inks & Paints Coatings Pharmaceuticals Agrochemicals Dyes & Pigments Personal Care End User Industries Printings Packaging Adhesives Fragrance & Flavour Paints & Coating Flame Redundant Electronic
Slide 7: Leadership Ambitions
Geared to Win Demonstrated 1 Cost and Technology leadership capability of Leadership absorbing and Market leadership – top 3 in scaling best in 2 Essentials (ex-China) and top class 5 in Specialties globally technologies Sufficient financial muscle 3 Partner of choice for customers to invest Large B
Slide 8: Track Record of technology absorption and in-house R&D capabilities
Track Record of technology absorption and in-house R&D capabilities ◼ Acquisition of Ketene/Diketene ◼ Addition of >40 New Derivatives for multiple industries business 2010 including agro and pharma and CASE to the ◼ Acquired know-how of some Specialties Platform acquired from Clariant derivatives f
Slide 9: Strategically located Manufacturing Sites
Strategically located Manufacturing Sites Europe Mahad (2 Sites) As part of the global footprint, we have offices in Amsterdam (Netherlands) and Shanghai (China). Tank • Land parcel: 45 acres operations in Belgium and Italy. • Land Occupancy: 90% China • Product Mix: o Essentials – 60% o Specialties
Slide 10: Network and Alliances
Network and Alliances Ravi Goenka Dr Rajan Venkatesh Harshvardhan Goenka Rajeev Goenka Manish Chokhani Executive Chairman Managing Director & Chief Executive Director – Strategy Non-Executive Director Non-Executive Director Executive Officer & Business Development Bachelor’s degree in Chemical Maste
Slide 11: Strong Management Team
Strong Management Team Harshvardhan Goenka Dr. Milind Vaidya Executive Director Executive Vice President (R&D and Specialties Marketing) B.Sc. (Babson College, School of Business, Boston, USA) Doctorate in Science (ICT, Mumbai) 11 years of experience (Laxmi Organic) 25+ years of experience in R&D, b
Slide 12: Our Core Values and Integrated EHS Program
Our Core Values and Integrated EHS Program Lost Time Injury (LTI) and Process Safety incident (PSI) targets for VPs and above Employee Health & Safety INTEGRITY INNOVATION Accident and EHS Risk To do what is right in the To create a culture where Incident Analysis Assessment interest of all our stak
Slide 13: Accreditation & Certification
Accreditation & Certification Recognized for its sustainable practices Accredited facilities Going beyond the regulatory compliances Biobased Product Label for Ethyl Acetate Ranked in 68th percentile globally in EcoVadis Sustainability Rating LAXMI ORGANIC INDUSTRIES LIMITED | Q1FY26 12
Slide 14: Accreditation & Certification
Accreditation & Certification Mahad Cluster – Site 1 & Site 2 – Certified for ISO 15001:2018 International Standard Implementation of Energy Management System (EnMS) LAXMI ORGANIC INDUSTRIES LIMITED | Q1FY26 13
Slide 15: Laxmi achieves BIS Certification
Laxmi achieves BIS (Bureau of Indian Standards) Certification BIS (Bureau of Indian Standards) Certification First Time in India – License to use ISI Mark for three products Acetic Anhydride, Ethyl Acetate and Methyl Ester LAXMI ORGANIC INDUSTRIES LIMITED | Q1FY26 14
Slide 16: Geared for Growth – Strategic Plan
Geared for Growth - Strategic Plan www.laxmi.com
Slide 17: Geared for Growth: Historical Performance
Geared for Growth: Historical Performance Growth Fueled by Strategic Acquisitions, Fast Technology Absorption together with achieving >20%+ Revenue Contribution from New Products launched in last 5 years Capacity Addition for ethyl acetate and acetaldehyde ◼ Acquired Ketene / Foray into Diketene bus
Slide 18: Geared for Growth: Positioned for the next Growth Phase
Geared for Growth: Positioned for the next Growth Phase Pivoted for the Next Growth Customer Needs Proven Success Phase Innovation 1 Product 1 Customer 2 2 Platform Plant Transited Price Product 3 Platform 3 Plant Strategic shift to Customer Centric Business Approach helped us gain more market and i
Slide 19: Geared for Growth: Financial Steering for FY28 Plan
Geared for Growth: Financial Steering for FY28 Plan Essentials Specialties Ketene/ Other / New Technology Platform Esterification Acetylation Fluorination Diketene Platforms Asset Turn Asset Turn 3x - 5x 1x - 2x Targeted Financial KPIs EBITDA Margin EBITDA Margin 8-12% 20-25% Combined ROCE of 20% LA
Slide 20: Consolidated Enterprise
Consolidated Enterprise (in INR Mn.) Capex Plan Revenue EBITDA* ROCE ~2x ~2.7x 7,500 20% 3,500 28,650 10% 2,839 FY 25 & 26 FY 26-28 FY 24 FY 28 E FY 24 FY 28 E FY24 FY28 E Key Highlights: Incremental Capex Investment Plan of ~ INR 11,000 Mn • On Consolidated basis the company plans to achieve RoCE:
Slide 21: Essentials: Strategy and Right to Win
Essentials: Strategy and Right to Win Go Deeper, Go Broader Strategy Grow in the Existing Products Enter in New Products • Retain India market share • Portfolio expansion • Grow exports • De-risking of business • Focus on continuous operational efficiencies • Future ready for biobased products Lean
Slide 22: Specialties: Strategy and Right to Win
Specialties : Strategy and Right to Win Specialties Growth Drivers Strategy Expand & Optimise in Incumbents Enter in New Products • Grow market share • Fluro assets to start delivering revenue in FY25 • Focus on global customers • To have min. 20% sales from new products • Improve cost leadership vi
Slide 23: Financial Highlights Q1FY26
Financial Highlights Q1FY26 www.laxmi.com
Slide 24: From the desk of MD & CEO
From the desk of MD & CEO Q1FY26 Reflections The global chemical industry has been marked by continued efforts towards cost optimization, rerouting supply chain linked to evolving tariffs and regional conflicts, and a strong push towards innovation. Regional dynamics continue to play a crucial role
Slide 25: Capex Update – Dahej
Capex Update – Dahej Inorganic EC Received on 04-May-24 Bhoomi Pujan at Dahej Site on 10-May-24 Civil foundation completed. Organic CTE received on Other activities progressing 20-Jun-24 on schedule. Q1 Q2 Q3 Q1 FY25 FY25 FY25 FY26 EC and Factory License Public hearing received for Dahej site Comple
Slide 26: Capex Update – Lote
Capex Update – Lote COVID period Acquired Q3FY20 Q2 FY’21 Q3 FY’21 Q1 FY’22 Q3 FY’23 Acquisition of Land development Kilo Lab setup created at Civil & structural work Equipment's arrived from technology and assets work started at Lote Mahad - familiarization to completed Italy from Miteni, Italy Mit
Slide 27: Consolidated Financial Highlights – Q1FY26
Consolidated Financial Highlights – Q1FY26 (in INR Mn.) Revenue Adjusted EBITDA PAT Key Highlights vs Q1FY25 -4% -46% -38% • Total volumes grew by 8% 7,182 6,929 712 344 • Consolidated Revenue dropped 214 by 4% due to reduction of Acetic 387 Acid prices in the Essentials 79 segment and on account of
Slide 28: Consolidated Business Highlights – Q1FY26
Consolidated Business Highlights – Q1FY26 (in INR Mn.) Essentials Revenue Specialties Revenue +4% -18% 4,858 2,523 Anticipated phase out of 4,659 a product serving the 2,071 agricultural solutions industry and deferment of deliveries of few products impacted revenue in Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1
Slide 29: De-risking continues to Deliver
De-risking continues to Deliver* Exports Continue to remain Relevant Revenue from Top 10 Customers 30% 30% 35% 36% 34% 27% 26% 23% 70% 70% 65% 64% FY23 FY24 FY25 Q1FY26 FY23 FY24 FY25 Q1FY26 Exports Domestic *On consolidated basis LAXMI ORGANIC INDUSTRIES LIMITED | Q1FY26 28
Slide 30: Export Revenue Break-up and Industry Wise Revenue
Export Revenue Break-up De-risking continues to Deliver FY24 Vs FY25 Q1FY25 Vs Q1FY26 26% 24% 24% 32% 31% 32% 38% 41% FY24 FY25 Q1FY25 Q1FY26 2% 8% 17% 15% 7% 3% 14% 4% 7% 5% 17% 15% 8% 10% 9% 10% Americas Europe Middle East Rest of Asia Pacific Africa China FY24 Vs FY25 Q1FY25 Vs Q1FY26 Industry Wi
Slide 31: Consolidated Profit & Loss – Q1FY26
Consolidated Profit & Loss – Q1FY26 (in INR Mn.) Particulars (Rs. Mn) Consolidated Q1FY26 Q1FY25 Y-o-Y Q4FY25 Q-o-Q FY25 FY24 Y-o-Y Revenue from operations 6,929 7,182 -3.5% 7,097 -2.4% 29,854 28,550 4.6% COGS 4,794 4,630 4,639 19,476 19,248 -0 Gross Margin 2,136 2,551 -16.3% 2,458 -13.1% 10,378 9,3
Slide 32: Operating expenses bridge YoY
Operating expenses bridge YoY (in INR Mn.) 1839 1,828 One time project costs 0 79 79 110 --One time project costs 19 39 Operating Expenses 1839 1,749 --Operating Expenses Q1’25 Lower costs Forex gain Lote One time Q1’26 to serve operations project costs LAXMI ORGANIC INDUSTRIES LIMITED | Q1FY26 31
Slide 33: Thank You
Thank You Company: Laxmi Organic Industries Limited Investor Relations: Strategic Growth Advisors Pvt. Ltd. www.laxmi.com www.sgapl.net CIN: L24200MH1989PLC051736 CIN: U74140MH2010PTC204285 Mr. Sagar Shroff / Mr. Tanay Shah Mr. Aniket Hirpara Email: sagar.shroff@sgapl.net / tanay.shah@sgapl.net Emai
Laxmi Organic Industries — Q1 FY26 Earnings Presentation on 6ix